Phio Pharmaceuticals Corp... (PHIO)
1.41
-0.02 (-1.40%)
At close: Feb 28, 2025, 3:59 PM
1.39
-1.42%
After-hours: Feb 28, 2025, 07:55 PM EST
Phio Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 8.49M | 11.78M | 24.06M | 14.24M | 6.93M | 14.88M | 3.58M | 12.91M | 5.12M | 8.5M | 11.39M | 5.13M | 503K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.5M | n/a | 3M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 154.5K | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 3K | 24K | 27K | 18K | 18K | n/a | 18K | 22.5K | 18K | 18K | 18K | 2K | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 597K |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 832K | 665K | 670K | 920K | 366K | 271K | 251K | 200K | 361K | 492K | 353K | 265K | 239K |
| Total Current Assets | 9.32M | 12.45M | 24.73M | 15.16M | 7.3M | 15.15M | 3.83M | 13.11M | 10.98M | 8.99M | 14.74M | 5.39M | 1.34M |
| Property-Plant & Equipment | 39K | 344K | 416K | 557K | 721K | 172K | 248K | 114K | 163K | 183K | 177K | 198K | 355K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 42K | 368K | 443K | 575K | 739K | 172K | 266K | 291K | 181K | 201K | 195K | 200K | 355K |
| Total Assets | 9.36M | 12.81M | 25.17M | 15.74M | 8.04M | 15.32M | 4.1M | 13.4M | 11.16M | 9.19M | 14.94M | 5.59M | 1.69M |
| Account Payables | 657K | 779K | 283K | 728K | 809K | 550K | 511K | 917K | 1.16M | 285K | 163K | 416K | 387K |
| Deferred Revenue | n/a | n/a | n/a | 1.25M | 937K | n/a | n/a | n/a | n/a | 47K | 118K | 491K | 816K |
| Short-Term Debt | 35K | 270K | 250K | 232K | 214K | n/a | n/a | n/a | n/a | n/a | n/a | 10K | 29K |
| Other Current Liabilities | 942K | 890K | 2.54M | 1.24M | 857K | 1.19M | 1.75M | 1.63M | 1.11M | 1M | 1.79M | 762K | 544K |
| Total Current Liabilities | 1.63M | 1.8M | 3.07M | 2.2M | 1.88M | 1.74M | 2.27M | 2.54M | 2.27M | 1.33M | 2.08M | 1.68M | 1.78M |
| Long-Term Debt | n/a | 35K | 170K | 526K | 411K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 505K |
| Other Long-Term Liabilities | n/a | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.11M | n/a | 9.73M | n/a |
| Total Long-Term Liabilities | n/a | 172K | 170K | 526K | 411K | n/a | n/a | n/a | n/a | 5.11M | 7.92M | 9.75M | 505K |
| Total Liabilities | 1.63M | 1.98M | 3.24M | 2.72M | 2.29M | 1.74M | 2.27M | 2.54M | 2.27M | 6.44M | 10M | 11.43M | 2.28M |
| Total Debt | 35K | 305K | 295K | 642K | 518K | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 534K |
| Common Stock | n/a | n/a | 1K | 1K | 1K | 2K | n/a | 1K | 7K | 2K | 1K | 16K | 10K |
| Retained Earnings | -139.21M | -128.38M | -116.9M | -103.61M | -94.82M | -85.91M | -78.55M | -66.1M | -57.1M | -46.88M | -38.08M | -17.16M | -4.28M |
| Comprehensive Income | -0.00 | n/a | 0.00 | n/a | n/a | -981K | -900K | -831K | -778K | -702K | -632K | -585K | -646K |
| Shareholders Equity | 7.73M | 10.84M | 21.93M | 13.02M | 5.75M | 13.58M | 1.83M | 10.86M | 8.89M | 2.75M | 4.94M | -5.84M | -587K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 154.5K | 5.5M | n/a | 3M | n/a | n/a |